Ropivacaine

Generic Name
Ropivacaine
Brand Names
Naropin
Drug Type
Small Molecule
Chemical Formula
C17H26N2O
CAS Number
84057-95-4
Unique Ingredient Identifier
7IO5LYA57N
Background

Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.

Indication

Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.

Associated Conditions
Acute Pain, Postoperative pain
Associated Therapies
Surgical anesthesia therapy
Clinical Trials
Related News

the Effect of Dexmedetomidine in Coracoid Approach Brachial Plexus Block

First Posted Date
2016-11-11
Last Posted Date
2023-02-15
Lead Sponsor
The First Hospital of Qinhuangdao
Target Recruit Count
60
Registration Number
NCT02961361

Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery

Phase 3
Completed
Conditions
Pain, Postoperative
Interventions
Drug: Placebos
Drug: Ropivacaine
First Posted Date
2016-11-09
Last Posted Date
2018-08-14
Lead Sponsor
BioQ Pharma, Inc.
Target Recruit Count
132
Registration Number
NCT02959476
Locations
🇺🇸

University of California, Irvine, Orange, California, United States

🇺🇸

Shoals Medical Trials, Inc., Sheffield, Alabama, United States

🇺🇸

Physician's Research Options, LLC- Corner Canyon OB/GYN, Draper, Utah, United States

and more 8 locations

Sensory Distribution of Lateral Femoral Cutaneous Nerve Block

First Posted Date
2016-11-08
Last Posted Date
2017-01-26
Lead Sponsor
Zealand University Hospital
Target Recruit Count
20
Registration Number
NCT02957903
Locations
🇩🇰

Zealand University Hospital, Køge, Køge, Denmark

Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty

First Posted Date
2016-11-03
Last Posted Date
2017-09-14
Lead Sponsor
National University Hospital, Singapore
Target Recruit Count
116
Registration Number
NCT02954484

Anesthesia for Pain After Ankle Fracture Surgery

First Posted Date
2016-11-01
Last Posted Date
2021-07-02
Lead Sponsor
University of Cincinnati
Target Recruit Count
14
Registration Number
NCT02950558
Locations
🇺🇸

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

🇺🇸

UC Health West Chester Hosptial, West Chester, Ohio, United States

Quadratus Lumborum Block for Abdominoplasty

First Posted Date
2016-10-31
Last Posted Date
2017-12-19
Lead Sponsor
Vestre Viken Hospital Trust
Target Recruit Count
50
Registration Number
NCT02949778
Locations
🇳🇴

Vestre Viken HT, Baerum Hospital, Sandvika, Norway

Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients

First Posted Date
2016-10-31
Last Posted Date
2018-12-31
Lead Sponsor
Instituto Mexicano del Seguro Social
Target Recruit Count
93
Registration Number
NCT02949674
Locations
🇲🇽

UMAE Dr. Victorio de La Fuente Narvaez, Ciudad de Mexico, Mexico

Comparison of PIEB vs CEI for Labor Analgesia

First Posted Date
2016-10-31
Last Posted Date
2019-01-11
Lead Sponsor
Duke University
Target Recruit Count
179
Registration Number
NCT02949271
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Optimal Volume, Rate, and Interval of Bolus Nerve Catheters for Shoulder Surgery

Phase 4
Withdrawn
Conditions
Pain
Interventions
Drug: Ropivacaine
First Posted Date
2016-10-27
Last Posted Date
2019-11-13
Lead Sponsor
Duke University
Registration Number
NCT02946268
Locations
🇺🇸

Duke Ambulatory Surgery Center, Durham, North Carolina, United States

Abdominal Wall Nerve Blockade: A Comparison With Local Port Site Injection as Well as Between the Use of Ultrasound and Laparoscopy to Guide Placement

First Posted Date
2016-10-26
Last Posted Date
2020-03-06
Lead Sponsor
Marcus Malek
Registration Number
NCT02945696
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy